High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations

Europace

Volumn 19, Issue 4, 2017, Pages 651-659

  Thevenon, Julien ^a   Laurent, Gabriel ^b,c   Ader, Flavie ^d   Laforêt, Pascal ^e   Klug, Didier ^f   Duva Pentiah, Anju ^f   Gouya, Laurent ^g   Maurage, Claude Alain ^f,h,i   Kacet, Salem ^f   Eicher, Jean Christophe ^b   Albuisson, Juliette ^j,k,l   Desnos, Michel ^j,k,l   Bieth, Eric ^m   Duboc, Denis ⁿ   Martin, Laurent ^o   Réant, Patricia ^p   Picard, François ^p   Bonithon Kopp, Claire ^o   Gautier, Elodie ^o   Binquet, Christine ^o   Thauvin Robinet, Christel ^a   Faivre, Laurence ^a   Bouvagnet, Patrice ^q   Charron, Philippe ^d,r   Richard, Pascale ^d   more..

^a Medical University of Dijon   (France)

^b HÔPITAL DU BOCAGE   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^h UNIV LILLE   (France)

ⁱ JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^j PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^k HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^l INSERM   (France)

^m CHU PURPAN   (France)

ⁿ Hôpital Purpan ^*  (France)

^o DIJON UNIVERSITY HOSPITAL   (France)

^p HAUT LÉVÊQUE HOSPITAL   (France)

^q UNIVERSITÉ LYON 1   (France)

^r LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

more..

Author keywords

Cardiomyopathy; PRKAG2; Time to event study; Ventricular pre excitation; Wolff Parkinson White

Indexed keywords

DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PRKAG2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CHILD; CLINICAL ARTICLE; DEFIBRILLATOR; DNA FLANKING REGION; DNA SEQUENCE; EXON; FEMALE; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GLYCOGEN STORAGE DISEASE; HEART GRAFT; HEART PREEXCITATION; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOKINESIA; LUNG EDEMA; MALE; MIDDLE AGED; MYOPATHY; PACEMAKER; PACEMAKER IMPLANTATION; PAROXYSMAL ATRIAL FIBRILLATION; PATHOGENESIS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PRKAG2 GENE; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SANGER SEQUENCING; SUDDEN CARDIAC DEATH; VENTRICULAR PREEXCITATION; WOLFF PARKINSON WHITE SYNDROME; YOUNG ADULT; COMORBIDITY; FRANCE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HEART ARRHYTHMIA; MORTALITY; MUTATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE;

ADULT; AMP-ACTIVATED PROTEIN KINASES; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, HYPERTROPHIC; COMORBIDITY; FEMALE; FRANCE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN STORAGE DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; SURVIVAL RATE;

EID: 85019123586     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euw067     Document Type: Article

References (20)

1. Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopathies. N Engl J Med 2011;364:1643-56.
2. Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 2002;109:357-62.
3. Frustaci A, Russo MA, Chimenti C. Diagnostic contribution of left ventricular en-domyocardial biopsy in patients with clinical phenotype of hypertrophic cardiomy-opathy. Hum Pathol 2013;44:133-41.
4. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995;333:288-93.
5. Austin SL, Proia AD, Spencer-Manzon MJ, Butany J, Wechsler SB, Kishnani PS. Cardiac pathology in glycogen storage disease type III. JIMD Rep 2012;6:65-72.
6. Yang Z, McMahon CJ, Smith LR, Bersola J, Adesina AM, Breinholt JP et al. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation 2005;112:1612-7.
7. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001;344:1823-31.
8. Gollob MH. Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome. Biochem Soc Trans 2003;31:228-31.
9. Murphy RT, Mogensen J, McGarry K, Bahl A, Evans A, Osman E et al. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomy-opathy and Wolff-Parkinson-White syndrome: natural history. J Am Coll Cardiol 2005;45:922-30.
10. Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001;10:1215-20.
11. Tan HL, van der Wal AC, Campian ME, Kruyswijk HH, ten Hove Jansen B, van Doorn DJ et al. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development. Circ Arrhythm Electrophysiol 2008;1:276-81.
12. Govindan M, Ward D, Behr E. A rare connection: fasciculoventricular pathway in PRKAG2 disease. J Cardiovasc Electrophysiol 2010;21:329-32.
13. Sternick EB, Oliva A, Gerken LM, Magalhaes L, Scarpelli R, Correia FS et al. Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fas-ciculoventricular pathway: the role of PRKAG2 mutation. Heart Rhythm 2011;8: 58-64.
14. Fabris E, Brun F, Porto AG, Losurdo P, Vitali Serdoz L, Zecchin M et al. Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. J Am Coll Cardiol 2013;62:e17.
15. Zhang LP, Hui B, Gao BR. High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson -White syndrome. J Electrocardiol 2011;44: 483-6.
16. Burwinkel B, Scott JW, Bührer C, van Landeghem FK, Cox GF, Wilson CJ et al. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phos-phorylase kinase deficiency. Am J Hum Genet 2005;76:1034-49.
17. Bayrak F, Komurcu-Bayrak E, Mutlu B, Kahveci G, Basaran Y, Erginel-Unaltuna N. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic car-diomyopathy in a Turkish family with a novel PRKAG2 mutation. Eur J Heart Fail 2006;8:712-5.
18. Liu Y, Bai R, Wang L, Zhang C, Zhao R, Wan D et al. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure. PLoS One 2013;8:e64603.
19. Laforêt P, Richard P, Said MA, Romero NB, Lacene E, Leroy JP et al. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis. Neuromuscul Disord 2006;16:178-82.
20. Charron P, Genest M, Richard P, Komajda M, Pochmalicki G. A familial form of conduction defect related to a mutation in the PRKAG2 gene. Europace 2007;9: 597-600.